Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

ISSN: 2253-1556


Editor-in-Chief: Professor Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

Latest articles:

- 5 records -

Cold Tumour Phenotype Explained Through Whole Genome Sequencing in Clinical Nasopharyngeal Cancer: A Preliminary Study

Handoko, Adham M, Rachmadi L, Wibowo H, Gondhowiardjo SA

ImmunoTargets and Therapy 2024, 13:173-182

Published Date: 18 March 2024

Dermatomyositis: Practical Guidance and Unmet Needs

Cassard L, Seraly N, Riegert M, Patel A, Fernandez AP

ImmunoTargets and Therapy 2024, 13:151-172

Published Date: 6 March 2024

Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article

Achdiat PA, Suwarsa O, Hidayat YM, Shafiee MN, Dwiyana RF, Hindritiani R, Sutedja E, Pudjiati SR, Hilmanto D, Dhamayanti M, Parwati I, Maharani RH, Sutedja EK, Avriyanti E, Yunitasari

ImmunoTargets and Therapy 2024, 13:123-150

Published Date: 5 March 2024

Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations

Zhang F, Ge Q, Meng J, Chen J, Liang C, Zhang M

ImmunoTargets and Therapy 2024, 13:111-121

Published Date: 26 February 2024


Read more articles